Journals / Turkish Journal of Gastroenterology / 2019 / Cilt: 30 - Sayı: 7

Dealing with the gray zones in the management of gastric cancer: The consensus statement of the İstanbul Group

Pages
584–598
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The recommendations are presented with the percentage of supporting votes in the results sectionwith related data.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The geographical location and differences in tumor biology significantly change the management of gastric cancer.
📊
Key Findings & Data:The uncertaintieslead to significant heterogeneities in clinical practice, lack of homogeneous data collection, and subsequently, diverse outcomes.The physicians who are professionally involved in the management of gastric cancer at two institutions in Istanbul, Turkey, organized aconsensus meeting to address current problems and plan feasible, logical, measurable, and collective solutions in their clinical practicefor this challenging disease.The evidence-based data and current guidelines were reviewed.
💡
Conclusion & Impact:The recommendations are presented with the percentage of supporting votes in the results sectionwith related data.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

The geographical location and differences in tumor biology significantly change the management of gastric cancer. The prevalence ofgastric cancer ranks fifth and sixth among men and women, respectively, in Turkey. The international guidelines from the Eastern andWestern countries fail to manage a considerable amount of inconclusive issues in the management of gastric cancer. The uncertaintieslead to significant heterogeneities in clinical practice, lack of homogeneous data collection, and subsequently, diverse outcomes.The physicians who are professionally involved in the management of gastric cancer at two institutions in Istanbul, Turkey, organized aconsensus meeting to address current problems and plan feasible, logical, measurable, and collective solutions in their clinical practicefor this challenging disease.The evidence-based data and current guidelines were reviewed. The gray zones in the management of gastric cancer were determinedin the first session of this consensus meeting. The second session was constructed to discuss, vote, and ratify the ultimate decisions.The identification of the T stage, the esophagogastric area, imaging algorithm for proper staging and follow-up, timing and patientselection for neoadjuvant treatment, and management of advanced and metastatic disease have been accepted as the major issues inthe management of gastric cancer. The recommendations are presented with the percentage of supporting votes in the results sectionwith related data.

🔖

Cite This Article

AYTAÇ, E., ASLAN, F., ÇİÇEK, B., ERDAMAR, S., GÜRSES, B., GÜVEN, K., FALAY, O., KARAHASANOĞLU, T., SELÇUKBİRİCİK, F., SELEK, U., ATALAR, B., BALIK, E., TÖZÜN, N., ROZANES, İ., ARICAN, A., HAMZAOĞLU, İ., BACA, B., MOLİNAS-MANDEL, N., SARUÇ, M., GÖKSEL, S., DEMİR, G., AĞAOĞLU, F. (2019). Dealing with the gray zones in the management of gastric cancer: The consensus statement of the İstanbul Group. Turkish Journal of Gastroenterology, Cilt: 30 - Sayı: 7, 584–598. https://ajindex.com/articles/410051

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2018. [CrossRef] 2. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354-62. [CrossRef] 3. HSGM. Cancer Statistics of Turkey in 2014. https://hsgm.saglik. gov.tr/tr/kanser-istatistikleri/yillar/495-2014-y%C4%B1l%C4%B1 -t%C3%BCrkiye-kanser-istatistikleri.html 4. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 2017; 20: 1-19. [CrossRef] 5. Ajani JA, D’Amico TA, Almhanna K, et al. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2016; 14: 1286-312. [CrossRef] 6. Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016; 27: v38-49. [CrossRef] 7. De Manzoni G, Marrelli D, Baiocchi GL, et al. The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015. Gastric Cancer 2017; 20: 20-30. [CrossRef] 8. Zilberstein B, Malheiros C, Lourenco LG, et al. Brazilian consensus in gastric cancer: guidelines for gastric cancer in Brazil. Arq Bras Cir Dig 2013; 26: 2-6. [CrossRef] 9. Martin-Richard M, Custodio A, Garcia-Giron C, et al. Seom guidelines for the treatment of gastric cancer 2015. Clin Transl Oncol 2015; 17: 996-1004. [CrossRef] 10. Kulig J, Wallner G, Drews M, et al. Polish Consensus on Treatment of Gastric Cancer; update 2017. Pol Przegl Chir 2017; 89: 59-73. [CrossRef] 11. Rice TW, Patil DT, Blackstone EH. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg 2017; 6: 119-30. [CrossRef] 12. Yalcin S. Gastric cancer in Turkey-a bridge between west and East. Gastrointest Cancer Res 2009; 3: 29-32. 13. Guner A. Recent trends of gastric cancer treatment in Turkey. Transl Gastroenterol Hepatol 2017; 2: 31. [CrossRef] 14. Roshandel G, Boreiri M, Sadjadi A, Malekzadeh R. A diversity of cancer incidence and mortality in West Asian populations. Ann Glob Health 2014; 80: 346-57. [CrossRef] 15. Pisters PWT, Kelsen DP, Tepper JE. Cancer of the stomach. In: DeVita VTJ, Hellman S, Rosenberg SA editors. Cancer: Principles and Practice of Oncology. 8 ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p.1043-7